Chromium is an essential nutrient involved in normal carbohydrate and lipid metabolism. The chromium requirement is postulated to increase with increased glucose intolerance and diabetes. The objective of this study was to test the hypothesis that the elevated intake of supplemental chromium is involved in the control of type 2 diabetes. Individuals being treated for type 2 diabetes (180 men and women) were divided randomly into three groups and supplemented with: 1) placebo, 2) 1.92 μmol (100 μg) Cr as chromium picolinate two times per day, or 3) 9.6 μmol (500 μg) Cr two times per day. Subjects continued to take their normal medications and were instructed not to change their normal eating and living habits. HbA1c values improved significantly after 2 months in the group receiving 19.2 pmol (1,000 pg) Cr per day and was lower in both chromium groups after 4 months (placebo, 8.5 ± 0.2%; 3.85 pmol Cr, 7.5 ± 0.2%; 19.2 pmol Cr, 6.6 ± 0.1%). Fasting glucose was lower in the 19.2-μmol group after 2 and 4 months (4-month values: placebo, 8.8 ± 0.3 mmol/1; 19.2 μmol Cr, 7.1 ± 0.2 mmol/1). Two-hour glucose values were also significantly lower for the subjects consuming 19.2 μmol supplemental Cr after both 2 and 4 months (4-month values: placebo, 12.3 ± 0.4 mmol/1; 19.2 μmol Cr, 10.5 ± 0.2 mmol/1). Fasting and 2-h insulin values decreased significantly in both groups receiving supplemental chromium after 2 and 4 months. Plasma total cholesterol also decreased after 4 months in the subjects receiving 19.2 μmol/day Cr. These data demonstrate that supplemental chromium had significant beneficial effects on HbA1c, glucose, insulin, and cholesterol variables in subjects with type 2 diabetes. The beneficial effects of chromium in individuals with diabetes were observed at levels higher than the upper limit of the Estimated Safe and Adequate Daily Dietary Intake.
Skip Nav Destination
Article navigation
Original Articles|
November 01 1997
Elevated Intakes of Supplemental Chromium Improve Glucose and Insulin Variables in Individuals With Type 2 Diabetes
Richard A Anderson;
Richard A Anderson
Beltsville Human Nutrition Research Center, U.S. Department of Agriculture
Beltsville, Maryland
Search for other works by this author on:
Nanzheng Cheng;
Nanzheng Cheng
Beijing Hospital, Beijing Medical University, and the General Hospital of Armed Police Force
Beijing, China
Search for other works by this author on:
Noella A Bryden;
Noella A Bryden
Beltsville Human Nutrition Research Center, U.S. Department of Agriculture
Beltsville, Maryland
Search for other works by this author on:
Marilyn M Polansky;
Marilyn M Polansky
Beltsville Human Nutrition Research Center, U.S. Department of Agriculture
Beltsville, Maryland
Search for other works by this author on:
Nanping Cheng;
Nanping Cheng
Beijing Hospital, Beijing Medical University, and the General Hospital of Armed Police Force
Beijing, China
Search for other works by this author on:
Jiaming Chi;
Jiaming Chi
Beijing Hospital, Beijing Medical University, and the General Hospital of Armed Police Force
Beijing, China
Search for other works by this author on:
Jinguang Feng
Jinguang Feng
Beijing Hospital, Beijing Medical University, and the General Hospital of Armed Police Force
Beijing, China
Search for other works by this author on:
Address correspondence and reprint requests to Dr. Richard A. Anderson, USDA, ARS, BHNRC, NRFL, Bldg. 307, Rm. 224, BARC-East, Beltsville, MD 20705-2350. E-mail: [email protected].
Diabetes 1997;46(11):1786–1791
Article history
Received:
March 03 1997
Revision Received:
July 08 1997
Accepted:
July 08 1997
PubMed:
9356027
Citation
Richard A Anderson, Nanzheng Cheng, Noella A Bryden, Marilyn M Polansky, Nanping Cheng, Jiaming Chi, Jinguang Feng; Elevated Intakes of Supplemental Chromium Improve Glucose and Insulin Variables in Individuals With Type 2 Diabetes. Diabetes 1 November 1997; 46 (11): 1786–1791. https://doi.org/10.2337/diab.46.11.1786
Download citation file:
1,163
Views